ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,444.00
0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) News

VTYX Ventyx Biosciences Inc

3.21
-0.075 (-2.28%)
Jun 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ventyx Biosciences Inc VTYX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.075 -2.28% 3.21 18:28:57
Open Price Low Price High Price Close Price Previous Close
3.26 3.035 3.37 3.26 3.285
more quote information »

Recent News

Date Time Source Heading
6/06/202415:05EDGAR2Form 8-K - Current report
6/05/202415:21EDGAR2Form 8-K - Current report
6/05/202415:01GLOBEVentyx Biosciences Announces Positive Preclinical Data for..
5/16/202415:05GLOBEVentyx Biosciences to Participate in Three Upcoming Investor..
5/16/202407:12EDGAR2Form 8-K - Current report
5/16/202407:00GLOBEVentyx Biosciences Announces Appointment of Matthew Moore as..
5/09/202415:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:06EDGAR2Form 8-K - Current report
5/09/202415:01GLOBEVentyx Biosciences Reports First Quarter 2024 Financial..
5/02/202415:05GLOBEVentyx Biosciences to Report First Quarter 2024 Financial..
4/26/202404:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
4/19/202405:00PRNUSVentyx Biosciences, Inc. Securities Fraud Class Action..
4/16/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
4/12/202404:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
4/09/202405:10PRNUSInvestors in Ventyx Biosciences, Inc. Should Contact The..
4/05/202404:45PRNUSInvestors who lost money on Ventyx Biosciences, Inc.(VTYX)..
3/29/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
3/26/202404:45PRNUSVentyx Biosciences, Inc. Sued for Securities Law Violations..
3/11/202408:01EDGAR2Form 8-K - Current report
3/11/202406:00GLOBEVentyx Biosciences Reports Clinical Data for its NLRP3..
3/11/202404:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
3/08/202415:05EDGAR2Form SC 13D/A - General statement of acquisition of..
3/07/202407:45EDGAR2Form 8-K - Current report
3/07/202407:00GLOBEVentyx Biosciences Announces $100 Million Private Placement..
3/07/202404:45PRNUSClass Action Filed Against Ventyx Biosciences, Inc. (VTYX)..
3/06/202407:00GLOBEVentyx Biosciences to Participate in Two Upcoming Investor..
3/04/202407:00GLOBEVentyx Biosciences to Host Virtual Investor Event on March..
2/27/202415:08EDGAR2Form 8-K - Current report
2/27/202415:01GLOBEVentyx Biosciences Reports Fourth Quarter and Full Year 2023..
2/22/202406:00GLOBEVentyx Biosciences to Present Results of the Phase 2 Trial..
2/13/202415:09EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
2/06/202415:05GLOBEVentyx Biosciences to Participate in the Oppenheimer 34th..
1/03/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202415:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/21/202319:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202318:22EDGAR2Form 144 - Report of proposed sale of securities
12/20/202318:10EDGAR2Form 144 - Report of proposed sale of securities
12/19/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:30EDGAR2Form 8-K - Current report
11/22/202315:57EDGAR2Form 8-K - Current report
11/21/202315:05GLOBEVentyx Biosciences to Participate in the 35th Annual Piper..
11/10/202307:00GLOBEVentyx Biosciences to Participate in the Jefferies London..
11/09/202315:05EDGAR2Form 8-K - Current report
11/09/202315:01GLOBEVentyx Biosciences Reports Third Quarter 2023 Financial..
11/07/202305:33IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..

Your Recent History

NASDAQ
VTYX
Ventyx Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved